EQUALISE – Patient Worthy

New Publication Validates Study of Lupus Nephritis Biomarker

Post author:Trudy Horsting
Post published:January 7, 2022
Post category:Lupus Nephritis

Equillium Inc. has just announced that their most recent study in lupus nephritis (LN) has been published in the Journal of Clinical Investigation. This study is thanks to collaboration with the Accelerated Medicines…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More